Seattle Genetics Inc.

Seattle Genetics, Inc. is a biotechnology company based in Bothell, Washington, a suburb of Seattle that houses many high-tech and biotech corporations.
The company is focused on enhancing the survival of cancer patients through monoclonal antibody (mAb)-based therapeutics that encompass four technology platforms, all of which are genetically engineered: single-chain immunotoxins (SCIT), antibody-drug conjugates (ADC), monoclonal antibodies (mAbs), and antibody-directed enzyme prodrug therapy (ADEPT).

Activity:

- Research & Development

Product / Technology type(s) covered:

- Bio
- Enzymes
- Pharmaceuticals / Therapeutics
- Reagents
- Technology

Therapeutic targets:

- Cancer
- Genetics

Markets Covered

a. HeadQuarter: United States of America

b. Continent(s) active:

c. Countries active:

Corporate data:

Number of Employees:

Turnover:

Amount:	Year:	Currency:

Year founded: